Neomycin sulfate, polymyxin B sulfate and dexamethasone ophthalmic suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neomycin sulfate, polymyxin B sulfate and dexamethasone ophthalmic suspension, covering 2023-07-21 to 2023-07-21. Get the full timeline:
Most recent: FDA Approved: NEOMYCIN POLYMYXIN B SULFATES AND DEXAMETHASONE — Supplemental Application (Bausch & Lomb Incorporated)